SEC Form 4 · accession 0001203311-17-000028
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vaughn B Himes
Officer — Chief Technical Officer
Period of report
May 31, 2017
Accepted (ET)
Jun 2, 2017 · 7:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 31, 2017 | M | 600 | $9.23 | A | 151,883 | D | |
| Common StockF3,F1 | May 31, 2017 | S | 600 | $63.41 | D | 151,283 | D | |
| Common StockF1 | May 31, 2017 | M | 9,400 | $9.23 | A | 160,683 | D | |
| Common StockF4,F1 | May 31, 2017 | S | 9,400 | $62.54 | D | 151,283 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F5 | $9.23 | May 31, 2017 | M | 600 | D | — | Apr 30, 2019 | Common Stock | 600 | 12,564 | D |
| Non-Qualified Stock Option (right to buy)F5 | $9.23 | May 31, 2017 | M | 9,400 | D | — | Apr 30, 2019 | Common Stock | 9,400 | 3,164 | D |
Explanation of responses
- F1Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F3Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $63.26 to $63.57. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F4Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $62.00 to $62.96. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F5Shares vested at a rate of 25% on 4/30/2010 and monthly thereafter until all the shares were fully vested on 4/30/2013.